Zusammenfassung
Die Haut nimmt trotz ihres im Vergleich zu anderen Organen einfachen Aufbaus und einer Dicke von nur wenigen Millimetern eine Vielzahl von Funktionen wahr. Sie bietet Schutz vor mechanischen, chemischen und thermischen Einflüssen und vermittelt als Sinnesorgan zwischen Körper und Umwelt. Erst in jüngster Zeit wurde erkannt, daß die Haut, als großflächiges Kontaktorgan ständig einer direkten Einwirkung von Fremdstoffen ausgesetzt, selbst eine aktive Rolle bei immunologischen Auseinandersetzungen übernimmt (Übersichten bei Patterson & Edelson, 1982; Streilein, 1983):
-
Keratinozyten produzieren hormon-ähnliche Moleküle, die in vielfältiger Weise Einfluß auf die Entwicklung und Funktion von Lymphozyten nehmen,
-
mit der Langerhans-Zelle besitzt die Haut einen eigenen, spezialisierten Zelltyp zur Präsentation von Antigenen,
-
es existieren T-Lymphozyten mit einer ausgeprägten Affinität zur Haut,
-
zwischen Haut und Thymus besteht eine strukturelle Verwandtschaft; beide Organe dienen als Reifungsort für Lymphozyten.
Unterstützt durch die Deutsche Forschungsgemeinschaft (Kö 427/7-3) und zeitweise durch den Deutschen Psoriasis-Bund
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Aoyagi T, Suya H, Kato N, Nemoto O, Kobayashi H, Miura Y (1985) Epidermal growth factor stimulates release of arachidonic acid in guinea pig epidermis. J Invest Dermatol 84: 168–171
Ashendel CL (1985) The phorbol ester receptor: a phospholipid-regulated protein kinase. Biochim Biophys Acta 822: 219–242
Barr RM, Brain S, Camp RDR, Cilliers J, Greaves MW, Mallet AI & Misch K (1984a) Levels of arachidonic acid and its metabolites in the skin in human allergic and irritant contact dermatitis. Br J Dermatol 111: 23–28
Barr RM, Wong E, Mallet AI, Olins LA & Greaves MW (1984b) The analysis of arachidonic acid metabolites in normal, uninvolved and lesional psoriatic skin. Prostaglandins 28: 57–65
Barrett ML, Lewis GP & Ward S (1986) Platelet activating factor modulates interleukin 2-induced proliferation of human T-lymphoblasts. Br J Pharmacol 89: 505P
Bauer R, Schütz R, Orfanos LE (1982) Granulozyten-Migration in Vitro bei Psoriasis-Patienten unter aromatischem Retinoid. Z Hautkr 57: 1247–1254
Bauer FW, van de Kerkhof PCM & Maassen-de Grood RM (1986) Epidermal proliferation following the induction of microabscesses by leukotriene B4. Br J Dermatol 114: 409–412
Bedford CJ, Young JM & Wagner BM (1983) Anthralin inhibition of mouse epidermal arachidonic acid lipoxygenase in vitro. J Invest Dermatol 81: 566–571
Berridge MJ (1984) Inositol triphosphate and diacylglycerol as second messengers. Biochem J 220: 345–360
Bloomfield FJ & Young MM (1982) Enhanced release of inflammatory mediators from lithium-stimulated neutrophils in psoriasis. Br J Dermatol 109: 9–13
Borgeat P & Samuelsson B (1979) Arachidonic acid metabolism in polymorphonuclear leukocytes: effects of ionophore A23187. Proc Natl Acad Sci USA 76: 2148–2152
Brain SD, Camp RDR, Dowd PM, Black AK, Woollard PM, Mallet AI & Greaves MW (1982) Psoriasis and leukotriene B4. Lancet II, 762–763
Bredeberg A & Forsgren A (1984) Effects of PUVA on human leukocyte function. Br J Dermatol 111: 159–168
Bremm K-D, Brom J, König W, Spur B, Crea A, Bhakdi S, Lutz F & Fehrenbach FJ (1983) Generation of leukotrienes and lipoxygenasefactors from human polymorphonuclear granulocytes during bacterial phagocytosis and interaction with bacterial exotoxins. Zbl Bakt Hyg, I. Abt Orig A 254: 500–514
Bremm K-D, König W, Pfeiffer P, Rauschen I, Theobald K, Thelestam M & Alouf JE (1985) Effect of thiol-activated toxins (streptolysin O, alveolysin, and theta toxin) on the generation of leukotrienes and leukotriene-inducing and -metabolizing enzymes from human polymorphonuclear granulocytes. Infect Immun 50: 844–851
Briggman RA, Schechter M, Fraki J, Lazarus GS (1984) Degradation of the epidermal-dermal junction by proteolytic enzymes from human skin and human polymorphonuclear leukocytes. J Exp Med 160: 1027–1042
Burrall BA, Wintroub BU & Goetzl EJ (1985) Selective expression of 15-lipoxygenase activity by cultured human keratinocytes. Biochem Biophys Res Comm 133: 208–213
Buselmeier TJ, Cantieri JS, Dahl MV, Nelson RS, Baumgärtner JC, Bentley CR & Golz RW (1979) Clearing of psoriasis after cardiaic surgery requiring cardiopulmonary bypass oxygenation: a corollary to clearance after dialysis? Br J Dermatol 100: 311–313
Camp RDR, Coutts AA, Greaves MW, Kay AB & Walport MJ (1983) Responses of human skin to intradermal injection of leukotrienes C4, D4, and B4. Br J Pharmacol 80: 497–502
Camp RDR, Mallet AI, Woollard PM, Brain SD, Kobza-Black AK & Greaves M (1983) The identification of hydroxy fatty acids in psoriatic skin. Prostaglandins 26: 431–447
Camp RDR, Rüssel Jones R, Woollard P & Greaves MW (1984) Production of intra-epidermal microabscesses by topical application of leukotriene B4. J Invest Dermatol 82: 202–204
Camp RDR & Fincham, NJ (1985) Inhibiton of ionophorestiMulated leukotriene B4-production in human leukocytes by monohydroxy fatty acids. Br J Pharmacol 85: 837–841
Cantieri JS, Graff G & Goldberg N (1980) Cyclic GMP metabolism in psoriasis: activation of soluble epidermal guanylate cyclase by arachidonic acid and 12-hydroxy-5,8,10,14-eicosate-traenoic acid. J Invest Dermatol 74: 234–237
Chan C-C & Ford-Hutchinson A (1985) Effects of synthetic leukotrienes on local blood flow and vascular permeability in porcine skin. J Invest Dermatol 84: 154–157
Chang J, Blazek E, Kreft AF & Lewis AJ (1985) Inhibition of platelet phospHolipase A2 by hydroxyeicosatetraenoic acids (HETES). A novel pharmacological mechanism for regulating free fatty acid release. Biochem Pharmacol 34: 1571–1575
Christophers E & Schröder JM (1981) Neutrophile Granulozytenchemotaxis und Psoriasis. Hautarzt 32, 558–563
Claesson H-E, Lundberg U & Malmsten C (1981) Serum coated zymosan stimulates the synthesis of leukotriene B4 in human polymorphonuclear leukocytes. Inhibition by cyclic AMP. Biochem Biophys Res CoMm 99: 1230–1237
Clancy RM, Dahindèn CA & Hugh TE (1983) Arachidonate metabolism by human polymorphonuclear leukocytes stimulated by N-formyl-Met-Leu-Phe or complement C5a is independent of phospholipase activation. Proc Natl Acad Sci USA 80: 7200–7204
Cook HW & Lands WM (1975) Further studies of the kinetics of oxygenation of arachidonic acid by soybean lipoxygenase. Can J Biochem 53: 1220–1231
Cream JJ & Pole DS (1980) The effect of methotrexate and hydroxyurea on neutrophil Chemotaxis. Br J Dermatol 102: 557–563
Csato M, Dobozy A, Hunjardi J, Keneressy SA & Simon N (1981) Polymorphonuclear granulocyte Chemotaxis and chemotactic factor generation by concanavalin-A stimulated peripheral blood mononuclear cells in patients with psoriasis. Arch Dermatol Res 271: 259–264
Csato M & Dobozy A (1981) A study of the candidakilling activity of polymorphonuclear leukocytes in patients with psoriasis vulgaris. Arch Dermatol Res 271: 229–231
Cunningham FM, Woollard PM & Camp RDR (1985) Proinflammatory properties of unsaturated fatty acids and the monohydroxy metabolites. Prostaglandins 30: 497–509
Czarnetzki BM, König W & Lichtenstein LM (1976) Eosinophil chemotactic factor (ECF). I Release from polymorphonuclear leukocytes by the calcium ionophore A23187. J Immunol 117: 229–234
Dahl KB, Nyfors A & Brodthagen H (1978) Decrease in neutrophils observed in vivo in psoriatics after PUVA therapy. Arch Dermatol Res 262:131–134
Dahlèn S-E, Björg J, Hedquist P, Arfors KE, Hammarström S, Lindgren JA & Samuelsson B (1981) Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response. Proc Natl Acad Sci USA 78: 3887–3891
Dahlèn S, Hansson G, Hedquist P, Bjorck T, Granström E & Dahlen B (1983) Allergen challenge of lung tissue from asthmatics elicits bronchial contraction that correlates with the release of leukotrienes C4, D4, and E4. Proc Natl Acad Sci USA 80: 1712–1716
Dowd RM, Woollard PM, Kobza-Black AK, Camp RDR & Greaves MW (1983) The effect of intradermal infusions of 12-hydroxyeicosatetraenoic acid (12-HETE) in normal human skin. Br J Dermatol 109: 693–694
Dubertret L, Lebreton C & Touraine R (1982) Inhibiton of neutrophil migration by etretinate and its main metabolite. Br J Dermatol 107: 681–685
Dusting GJ, Moneada S & Vane JR (1977) Prostacyclin (PGX) is the endogenous metabolite responsible for relaxation of coronary artieries by arachidonic acid. Prostaglandins 13: 3–15
Eaglestein WH, Sakai M & Mizuno N (1979) Ultraviolet radiation-induced inflammation and leukocytes. J Invest Dermatol 72: 59–63
Farrar WL & Humes JL (1985) The role of arachidonic acid metabolism in the activities of interleukin 1 and 2. J Immunol 135: 1153–1159
Feinmark SJ, Malmsten C & Claesson H-E (1983) Degranulation and cyclic AMP levels in leukotriene B4-stimulated human leukocytes. In: Samuelsson B, Paoletti R & Ramwell P (eds.) Advances in prostaglandin, thromboxane and leukotriene research 12: Raven Press New York, pp. 7–12
Feuerstein N, Foegh M & Ramwell PW (1981) Leukotrienes C4 and D4 induce prostaglandin and thromboxane release from rat peritoneal macrophages. Br J Pharmacol 72: 389–391
Fitzpatrick F, Liggett W, McGee J, Bunting S, Morton D & Samuelsson B (1984) Metabolism of leukotriene A4 by human erythrocytes. A novel cellular source of leukotriene B4. J Biol Chem 259: 11403–11407
Fitzsimmons BJ, Adams J, Evans JF, Leblanc Y & Rokach J (1985) The lipoxins. Stereochemical identification and determination of their biosynthesis. J Biol Chem 260: 13008–13012
Folco G, Hansson G & Granström E (1981) Leukotriene C4 stimulates TXA2 formation in isolated guinea pig lungs. Biochem Pharmacol 30: 2491–2493
Ford-Hutchinson AW, Bray MA, Doig MV, Shipley ME & Smith MJH (1980a) Leukotriene B4, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature 286: 264–265
Ford-Hutchinson AW, Brax MA & Smith MJH (1980b) Lipoxygenase products and the polymorphonuclear leukocyte. Agents Actions 10: 548–550
Forster S, Ilderton E, Summerly R & Yardley HJ (1983a) Epidermal phospholipase A2 activity is raised in the uninvolved skin of psoriasis. Brit J Dermatol 109 Suppl 25: 30–35
Forster S, Ilderton E, Summerly R & Yardley HJ (1983b) The level of phospholipase A2 activity is raised in the uninvolved epidermis of psoriasis. Br J Dermatol 108: 103–105
Garcia Gil GM, Alonso F, Chiva A, Crespo M & Mato JM (1982) Phospholipid turnover during phagocytosis in human polymorphonuclear leukocytes. Biochem J 206: 67–72
Gimbrone MA, Brock AF & Schafer (1984) Leukotriene B4 stimulates polymorphonuclear leukocyte adhesion to cultured vascular endothelial cells. J Clin Invest 74: 1552–1555
Glinski W, Jablonska S, Imiela J, Nosarzewski J, Sarzabek-Chorzelska M, Haftek M & Obalek S (1979) Continuous peritoneal dialysis for treatment of psoriasis. Arch Dermatol Res 265: 337–341
Glinski W, Barszcz D, Janczura E, Zarebska Z & Jablonska S (1984) Neutral proteinases and other neutrophil enzymes in psoriasis and their relation to disease activity. Br J Dermatol 111: 147–154
Goerig M, Habenicht AJR & Schettler G (1985) Eicosanoide und Phospholipasen. Klin Wochenschr 63: 293–311
Goetzl EJ & Pickett WC (1980) The human PMN leukocyte chemotactic activity of complex hydroxy-eicosatetraenoic acids (HETES). J Immunol 125: 1789–1791
Goetzl EJ (1982) The conversion of leukotriene C4 to isomers of leukotriene B4 by human eosinophil peroxidase. Biochem Biophys Res Comm 106: 270–275
Goetzl EJ, Brash AR, Tauber A, Oates JA & Hubbard WS (1980) Modulation of human neutrophil function by monohydroxy-eicosatetraenoic acids. Immunol 39: 491–501
Goetzl EJ, Chernov T, Renold R & Payan DG (1985) Neuropeptide regulation of the expression of immediate hypersensitivity. J Immunol 135: 802S–805S
Goldberg ND & Haddox MK (1977) Cyclic GMP metabolism and involvement in biological regulation. In: Ann Rev Biochem. Snell EE, Bozner PD, Meister A & Richardson CC (eds), Palo Alto, Annual Reviews, Inc, pp 823–896
Gorman RR, Lin AH & Hopkins NK (1984) Acetylglycerylether phosphocholine- (AGEPC) and leuktriene B4-stimulated cyclic AMP levels in human polymorphonuclear leukocytes. In: Greenard, P et al. (eds) Advances in cyclic nucleotide and protein phosphorylation research. Raven Press New York, pp. 631–638
Grabbe J, Czarnetzki BM & Mardin M (1982) Chemotactic leukotrienes in psoriasis. Lancet II, 1464.
Grabbe J, Czarnetzki BM, Rosenbach T & Mardin M (1984a) Identification of chemotactic lipoxygenase products of arachidonate metabolism in psoriatic skin. J Invest Dermatol 82: 477–479
Grabbe J, Czarnetzki BM & Mardin M (1984b) Release of lipoxygenase products of arachidonic acid from freshly isolated human keratinocytes. Arch Dermatol Res 276:128–130
Gualde N, Atluru D & Goodwin JS (1985) Effect of lipoxygenase metabolites of arachidonic acid on proliferation of human T cells and T cell subsets. J Immunol 134:1125–1129
Hafstrom I, Palmblad J, Malmsten CL, Radmark O & Samuelson B (1981) Leukotriene B4 — a stereospecific stimulator for release of lysosomal enzymes from neutrophils. FEBS Lett 130: 146–148
Ham EA, Soderman DD, Zanetti ME, Dougherty HW, McCauley E & Kuehl FA (1983) Inhibiton by prostaglandin of leukotriene B4 release from activated neutrophils. Proc Natl Acad Sci USA 80: 4349–4353
Hammarström S, Hamberg M, Samuelsson B, Duell EA, Stawiski M & Voorhees JJ (1975) Increased concentrations of non-esterified arachidonic acid, 12-L-hydroxy-5,8,10,14-eicosatetraenoic acid, prostaglandin E2 and prostaglandin F2a in epidermis of psoriasis. Proc Natl Acad Sci USA 72: 5130–5134
Hammarström S, Lindgren JA, Marcello C, Duell EA, Anderson TE & Voorhees J (1979) Arachidonic acid transformation in normal and psoriatic skin. J Invest Dermatol 73: 180–183
Hanna CJ, Bach MK, Pare PD & Schellenberg RR (1981) Slow reacting substances (leukotrienes) contract human airway and pulmonary vascular smooth muscle in vitro. Nature 290: 343–344
Hansson G, Lindgren JA, Dahlèn SE, Hedquist P & Samuelsson B (1981) Identification and biological activity of novel ω-oxidized metabolites of leukotriene B4 from human leukocytes. FEBS Lett. 130:107–112
Hansson G, Malmsten C & Radmark O (1983) The leukotrienes and other lipoxygenase products. In: Pace-Asciak CR & Granström E (eds) Prostaglandins and related substances. Elsevier Science Publishers BV, pp 127–169
Hauser C, Saurat J-H, Schmitt A, Jaunin F & Dayer JM (1986) Interleukin 1 is present in normal human epidermis. J Immunol 136: 3317–3323
Hawk JLM, Black AK, Jaenicke RF, Barr RM, Soter N, Mallet AI, Gilchrist BA, Hensby CN, Parrish JA & Greaves MW (1983) Increased concentrations of arachidonic acid and prostaglandins E2, D2, 6-oxo-F2α and histamine in human skin following ultraviolet A irridiation. J Invest Dermatol 80: 496–499.
Henderson WR & Klebanoff SJ (1983) Leukotriene B4, C4, D4, and E4 inactivation by hydroxyl radicals. Biochem Biophys Res Comm 110: 266–272
Herlin T & Borregaard N (1982) Increased rate of opsonization of zymosan by serum from patients with psoriasis. Arch Dermatol Res 273: 343–345
Jablonska S, Chorzelski TP, Beutner EH, Maciejowska E, Jarzabek-Chorzelska M & Rzesa G, (1978) Autoimmunity in psoriasis. Relation of disease activity and forms of psoriasis to immunofluorescence findings. Arch Dermatol Res 261: 135–146
Johnson HM & Torres BA (1984) Leukotrienes: positive signals to regulation of γ-interferon production. J Immunol 132: 413–416
Jones GH, Venuti MC, Young JM, Murthy DVK, Loe BE, Simpson RA, Berks AH, Spires DA, Maloney PJ, Kruseman M, Rouhafza S, Kappas KC, Beard CC, Unger SH & Cheung PS (1986) Topical non-steroidal antipsoriatic agents. 1.1,2,3,4-Tetraoxygenated naphtalene derivatives. J Med Chem 29: 1504–1511
Juhlin L & Hammarström S (1983) Wheal reactions in human skin after injection of leukotrienes B4, C4, D4, and E4. Prostaglandins, Leukotrienes & Medicine 11: 381–383
Jung G, Yang D-C & Nakao A (1985) Oxygenation of phosphatidylcholine by human polymorphonuclear leukocyte 15-lipoxygenase. Biochem Biophys Res Comm 130: 559–566
Kaben U & Westphal HJ (1986) Einfluß der PUVA-Therapie auf die Chemotaxis neutrophiler Granulozyten bei verschiedenen Psoriasisformen. Dermatol Monatsschr 172: 493–497.
Kikkawa U, Kaibuchi T, Takai Y & Nishizuka Y (1985) Phospholipid turnover in signal transduction: protein kinase C and calcium ion as two synergistic mediators. In: Kuo F (ed) Phospholipids and cellular regulation. Vol II, CRC Press, Inc, Boca Raton, Florida pp. 111–126
King, LE (1985) What does epidermal growth factor do and how does it do it? J Invest Dermatol 84: 165–167
König W, Czarnetzki BM & Lichtenstein LM (1976) Eosinophil chemotactic factor (ECF). II Release from human polymorphonuclear leukocytes during phagocytosis. J Immunol 117: 235–245
König W, Frickhofen N & Tesch H (1979) Generation and secretion of eosinophilotactic activity from human polymorphonuclear neutrophils by various mechanisms of cell activation. Immunol 36: 733–742
Kondoh H, Sato Y & Kanoh H (1985) Arachidonic acid metabolism in cultured mouse keratinocytes. J Invest Dermatol 85: 64–69
Kragballe K, Desjarlais L, Duell EA & Voorhees JJ (1986) In vitro synthesis of 12-hydroxy-eicosatetraenoic acid is increased in uninvolved psoriatic epidermis. J Invest Dermatol 87: 47–52
Krögel C, König W, Mollay C & Krell G (1981) Generation of the eosinophil chemotactic factor (ECF) from various cell types by melittin. Mol Immunol 18: 227–236
Kröner EE, Peskar BA, Fischer H & Ferber E (1981) Control of arachidonic acid accumulation in bone marrow-derived macrophages by acyltransferases. J Biol Chem 256: 3690–3697
Kunkel SL & Chensue SW (1985) Arachidonic acid metabolites regulate interleukin-1 production. Biochem Biophys Res Comm 128: 892–897
Kunkel SL, Chensue SW & Phan SH (1986) Prostaglandins as endogenous mediators of interleukin 1 production. J Immunol 136:186–192
Lands, WEM (1984) Biological consequences of fatty acid oxygenase reaction mechanisms. Prostaglandins Leukotrienes Medicine 13: 35–46
Langner A (1983) Is chemotactic activity of polymorphonuclear leukocytes increased in psoriasis? Arch Dermatol Res 275: 226–228
Lazarus GS, Yost FJ & Thomas CA (1977) Polymorphonuclear leukocytes: possible mechanisms of accumulation in psoriasis. Science 198: 1162–1163
Lee CW, Lewis RA, Tauber AI, Mehrota M, Corey EJ & Austen KF (1983) The myeloperoxidase-dependent metabolism of leukotrienes C4, D4, and E4 to 6-trans-leukotriene B4 diastereoisomers and the subclass-specific S-diastereoisomeric sulfoxides. J Biol Chem 258: 15004–15010
Lee TC & Snyder F (1985) Function, metabolism, and regulation of platelet activating factor and related ether lipids. In: Kuo F (ed) Phospholipids and cellular regulation. Vol II, CRC Press, Inc, Boca Raton, Florida, pp 1–39
Lewis RA, Austen KF, Drazen JM, Clark DA, Marfat A & Corey EJ (1980) Slow reacting substances of anaphylaxis: identification of leukotrienes C-1 and D from human and rat sources. Proc Natl Acad Sci USA 77: 370–3714
Lundin A, Hakansson L, Hällgren R, Michaelsson G & Vege P (1985) Increased in vivo secretory activity of neutrophil granulocytes in patients with psoriasis and palmoplantar pustulosis. Arch Dermatol Res 277: 179–184
Maclouf J, Fruteau de Laclos, B & Borgeat, P (1983) Effects of 12-hydroxy- and 12-hydro-peroxy-5, 8,10,14-eicosatetraenoic acid on the synthesis of 5-hydroxy-6,8,11,14-eicosatetraenoic acid and leukotriene B4 in human blood leukocytes. In: Samuelsson B, Paoletti R & Ramwell P (eds) Advances in prostaglandin, thromboxane and leukotriene research 11: Raven Press New York, pp 159–162
Malmsten CL, Palmblad J, Uden AM, Radmark O, Engstedt L & Samuelsson B (1980) Leukotriene B4: a highly potent and stereospecific factor stimulating migration of polymorphonuclear leukocytes. Acta Physiol Scand 110: 440–451
Marcus AJ, Safier LB, Broekman J, Ullman HL, Islam N, Sorrell TC, Serhan CN, Weissman G, Oglesby TD & Gorman RR (1984) Production of metabolic products of arachidonic acid during cell-cell-interactions. J Allergy Clin Immunol 74: 338–341
Marcus AJ, Weksler BB, Jaffe EA & Broekman MJ (1980) Synthesis of prostacyclin from platelet-derived endoperoxides by cultured human endothelial cells. J Clin Invest 66: 979–986
Marcus AJ, Broekman MJ, Safier LB, Ullman HL & Islam N (1982) Formation of leukotrienes and other hydroxy acids during platelet-neutrophil interactions in vivo. Biochem Biophys Res Comm 109: 130–137
Maurice PDL, Allen BR, Heptinstall S & Bather PC (1986 a) Arachidonic acid metabolism by peripheral blood cells in psoriasis. Br J Dermatol 114: 553–566
Maurice PDL, Bather PC & Allen BR (1986b) Arachidonic acid metabolism by polymorphonuclear leukocytes in psoriasis. Br J Dermatol 114: 57–64.
McGee JE & Fitzpatrick FA (1986) Erythrocyte-neutrophil interactions: formation of leukotriene B4 by transcellular biosynthesis. Proc Natl Acad Sci USA 83: 1349–1353
Mexmain S, Cook J, Aldigier J-C, Gualde N & Rigaud M (1985) Thymocyte cyclic AMP and cyclic GMP response to treatment with metabolites from the lipoxygenase pathway. J Immunol 135: 1361–1365
Michaelsson G (1980) Increased chemotactic activity of neutrophil leukocytes in psoriasis. Br J Dermatol 103: 351–356
Mingrone G, Greco AV, Venier A, Peruzzi E & Serri F (1980) Lipid synthesis from the liver in patients with psoriasis. Arch Dermatol Res 268: 271–276
Nadeau M, Fruteau de Laclos B, Picard S, Braquet P, Corey EJ & Borgeat P (1984) Studies on leukotriene B4 ω-oxidation in human leukocytes. Cand J Biochem Cell Biol 62: 1321–1326
Nahorsky, SR (1985) Inositol phospholipid hydrolysis as a primary response to receptors not linked to adenylate cyclase. Arzneim-Forsch/Drug Res 35: II, 1886–1890
Nissen H-P, Kreysel H-W & Schulz D-K (1982) Zusammensetzung der freien Fettsäuren bei der Psoriasis vulgaris. Hautarzt 33: 145–147
Oliw E, Granström E & Änggard E (1983) The prostaglandins and essential fatty acids. In: Pace-Asciak CR & Granström E (eds) Prostaglandins and related substances. Elsevier Science Publishers BV, pp. 1–43
Patterson JAK & Edelson RL (1982) Interaction of T cells with the epidermis. Br J Dermatol 107: 117–122
Payan DG, Missirian-Bastian A & Goetzl EJ (1984) Human T-lymphocyte subset specificity of the regulatory effects of leukotriene B4. Proc Natl Acad Sci USA 81: 3501–3505
Penneys NS, Ziboh VA, Lord J & Simon P (1976) Inhibitor(s) of prostaglandin synthesis in psoriatic plaque. Nature 254: 351–352
Pernow B (1985) The role of tachykinins in neurogenic inflammation. J Immunol 135: 812S–815S
Pagatto PD, Riva F, Aaltomare GF, Brugo AM, Morandotti A & Finzi AF (1984) Effect of etretinate on Chemotaxis of neutrophils from patients with pustular and vulgar psoriasis. J Invest Dermatol 81: 418–419
Pologe LG, Cramer EG, Pawlowski NA, Abraham E, Conn ZA & Scott WA (1984) Stimulation of human endothelial cell prostacyclin synthesis by select leukotrienes. J Exp Med 160: 1043–1053
Powell PS (1984) Properties of leukotriene B4 20-hydroxylase from polymorphonuclear leukocytes. J Biol Chem 259: 3082–30890
Preissner WC, Schröder JM & Christophers E (1983) Altered polymorphonuclear leukocyte responses in psoriasis: degranulation and Chemotaxis. Br J Dermatol 109: 1–8
Radoux V, Gagnon L, Pouliot C, Corey EJ & Rola-Pleszczynski M (1984) Differential immuno-regulatory effects of LTB4 and its analogs. Fed Proc 43: 1806
Ragaz A & Ackerman AB (1979) Evolution, maturation and regression of lesions of psoriasis. Am J Dermatopathol. 1: 199–203
Ramesha CS & Pickett WC (1986) Platelet-activating factor and leukotriene biosynthesis is inhibited in polymorphonuclear leukocytes depleted of arachidonic acid. J Biol Chem 261: 7592–7595
Rankin JA (1986) IgE immune complexes induce leukotriene B4 release from rat alveolar macrophages. Ann Inst Pasteur/Immunol 137C: 364–367
Rapoport S, Härtel B & Hausdorf G (1984) Methionine sulfoxide formation: the cause of self-inactivation of reticulocyte lipoxygenase. Eur J Biochem 139: 573–576
Rice RH & Levine L (1984) Melittin-stimulated arachidonie acid metabolism by cultured malignant human epidermal keratinocytes. Biochem Biophys Res Comm 124: 303–307
Rola-Pleszczynski M, Gagnon L, Rudzinska M, Borgeat P & Sirois P (1982) Human natural cytotoxic cell activity: enhancement by leukotrienes (LT) A4, B4, and D4, but not by stereoisomers of LTB4 or HETEs. Prostaglandins, Leukotrienes and Medicine 13: 113–117
Rola-Pleszczynski M, Borgeat P & Sirois P (1984) Leukotriene B4 induces human suppressor lymphocytes. Biochem Biophys Res Comm 108: 1531–1537
Rola-Pleszczynski M (1985) Differential effects of leukotriene B4 on T4+ and T8+ lymphocyte phenotype and immunoregulatory functions. J Immunol 135: 1357–1360.
Rouzer CA, Shimizu T & Samuelsson B (1985) On the nature of the 5-lipoxygenase reaction in human leukocytes: characterization of a membrane-associated stimulatory factor. Proc Natl Acad Sci USA 82: 7505–7509
Rouzer CA & Samuelsson B (1985) On the nature of the 5-lipoxygenase reaction in human leukocytes: enzyme purification and requirement for multiple stimulatory factors. Proc Natl Acad Sci USA 82: 6040–6044
Rouzer CA, Matsumoto T & Samuelsson B (1986) Single protein from human leukocytes possesses 5-lipoxygenase and leukotriene A4 synthase activities. Proc Natl Acad Sci USA 83: 857–861
Rouzer CA & Samuelsson B (1986) The importance of hydroperoxide activation for the detection and assay of mammalian 5-lipoxygenase. FEBS Lett 204: 293–296
Ruzicka T & Printz MP (1982) Arachidonic acid metabolism in guinea pig skin. Biochim Biophys Acta 711: 391–397
Ruzicka T, Walter JF & Printz MP (1983) Changes in arachidonic acid metabolism in UV-irradiated hairless mouse skin. J Invest Dermatol 81: 300–303
Ruzicka T, Simmet T, Peskar BA & Ring, J (1986) Skin levels of arachidonic acid-derived inflammatory mediators and histamine in atopic dermatitis and psoriasis. J Invest Dermatol 86: 105–108
Schopf RE, Altmeyer P & Lemmel EM (1982) Increased respiratory burst activity of monocytes and polymorphonuclear leukocytes in psoriasis. Br J Dermatol 107: 505–510
Schröder JM & Christophers E (1985) Transient absence of C5a-specific neutrophil functions in inflammatory disorders of the skin. J Invest Dermatol 85: 194–198
Schröder JM & Christophers E (1986) Identification of C5a des arg and anionic neutrophil-activating peptide (ANAP) in psoriatic scales. J Invest Dermatol 87: 53–58
Sedgwick JB, Bergstresser PR & Hurd ER (1979) Granulocytosis and increased granular adherence in psoriasis and psoriatic arthritis. Clinical research 27: 245 a
Sedgwick JB, Hurd ER & Bergstresser PR (1982) Abnormal granulocyte morphology in patients with psoriasis. Br J Dermatol 107: 165–172
Sedgwick JB, Bergstresser PR & Hurd ER (1980) Increased granulocyte adherence in psoriasis and psoriatic arthritis. J Invest Dermatol 74: 81–84
Serhan CN, Hamberg M & Samuelsson B (1984 b) Lipoxins: a novel series of biologically active compounds formed from arachidonic acid in human leukocytes. Proc Natl Acad Sci USA 81: 5335–5339
Serhan CN, Hamberg M & Samuelsson B (1984b) Trihydroxytetraens: a novel series of compounds formed from arachidonic acid in human leukocytes. Biochem Biophys Res Comm 118: 943–949
Shak S & Goldstein IM (1985) Leukotriene B4 ω-hydroxylase in human polymorphonuclear leukocytes. Partial purification and identification as a cytochrome P450. J Clin Invest 76: 1218–1228
Shimizu T, Izumi T, Seyama Y, Tadokoro K, Radmark O & Samuelsson B (1986) Characterization of leukotriene A4-synthase from murine mast cells: evidence for its identity to arachidonate 5-lipoxygenase. Proc Natl Acad Sci USA 83: 4175–4179
Showell HJ, Naccache PH, Borgeat P, Picard S, Vallerand P, Becker EL & Sha’afi RA (1982) Characterization of the secretory activity of leukotriene B4 toward rabbit neutrophils. J Immunol 128: 811–816
Sircar JC & Schwender CF (1983) Antipsoriatic drugs as inhibitors of soybean lipoxygenase. Prostaglandins, Leukotrienes and Medicine 11: 373–380
Skott A, Mobacken H & Starmark JE (1977) Exacerbation of psoriasis during lithium treatment. Br J Dermatol 96: 445–448
Soberman RJ, Harper TW, Murphy RC & Austen KF (1985) Identification and functional characterization of leukotriene B4 20-hydroxylase of human polymorphonuclear leukocytes. Proc Natl Acad Sci USA 82: 2292–2295
Soltani K & van Scott EJ (1972) Patterns and sequence of tissue changes in incipient and evolving lesions of psoriasis. Arch Dermatol 106: 484–487
Soter NA, Lewis RA, Corey EJ & Austen KF (1983) Local effects of synthetic leukotrienes (LTC4, LTD4, LTE4, and LTB4) in human skin. J Invest Dermatol 80: 115–119.
Spiegelberg HL, Melewicz FM & Ferreri NR (1986) IgE receptors on monocytes and allergy. Ann Inst Pasteur/Immunol 137C: 358–363
Stodtmeister W, Nissen HP, Schirren C & Kreysel HW (1979) Fettsäure-Verteilung der Haarlipide bei der Psoriasis vulgaris. Arch Dermatol Res 264: 339–343
Streilein JW (1983) Skin-associated lymphoid tissues (SALT): origins and functions. J Invest Dermatol 80: 12S–16S
Stüning M, Schultz-Ehrenburg U, Altmeyer P, Raulf M & König W (1986) Metabolism of (14C) arachidonic acid by polymorphonuclear leukocytes in patients with psoriasis. Br J Dermatol, in press
Summerly R, Ilderton E & Gray GM (1978) Possible defects in triacylglycerol and phosphatidylcholine metabolism in psoriatic epidermis. Br J Dermatol 99: 279–288
Tagami H & Ofuji S (1976) Leukotactic properties of soluble substances in psoriatic scale. Br J Dermatol 95: 1–8
Takematsu H, Ohkohchi K & Tagami H (1986 a) Demonstration of anaphylatoxins C3a, C4a, and C5a in the scales of psoriasis and inflammatory pustular dermatoses. Br J Dermatol 114:1–6
Takematsu H, Suzuki R, Tagami H & Kumagi K (1986b) Interleukin-1-like activity in scale extracts of psoriasis and sterile pustular dermatoses. Dermatologica 172: 236–240
Touqui L, Rothhut B, Shaw AM, Fradin A, Vargraftig BB & Russo-Marie F (1986) Platelet activation: a role for a 40K anti-phospholipase A2 protein indistinguishable from lipocortin. Nature 321: 177–180
Tripp CS, Mahoney M & Needleman P (1985) Calcium ionophore enables soluble agonists to stimulate macrophage 5-lipoxygenase. J Biol Chem 260: 5895–5898
Tsambaos D, Kalafoutis A, Stratigos J, Miras C & Capetanakis J (1977) Thin-layer chromatography of phospholipid components of normal and psoriatic epidermis. Br J Dermatol 97: 135–138
Ueda N, Kaneko S, Yoshimoto T & Yamamoto (1986) Purification of arachidonate 5-lipoxygenase from porcine leukocytes and its reactivity with hydroperoxyeicosatetraenoic acid. J Biol Chem 261: 7982–7988
Vahlquist C, Berne B, Boberg M, Michaelsson G & Vessby B (1985) The fatty acid spectrum in plasma and adipose tissue in patients with psoriasis. Arch Dermatol Res 278: 114–119
Valdimarsson H, Baker BS, Jonsdottir I & Fry L (1986) Psoriasis: a disease of abnormal keratinocyte proliferation induced by T lymphocytes. Immunology today 7: 256–259
Van de Kerkhof PCM, Bauer FW & Massen-de Grood RM (1985) Methotrexate inhibits the leukotriene B4 induced intraepidermal accumulation of polymorphonuclear leukocytes. Br J Dermatol 113: 251a–255a
Vanderhoek JY, Bryant RW & Bailey JM (1980a) Inhibition of leukotriene biosynthesis by the leukocyte product 15-hydroxy-5,8,11,13-eicosatetraenoic acid. J Biol Chem 255: 10064–10066
Vanderhoek JY, Bryant RW & Bailey JM (1980b) 15-Hydroxy-5,8,11,13-eicosatetraenoic acid. A potent and selective inhibitor of platelet lipoxygenase. J Biol Chem 255: 5996–5998
Walker A, Cohen H, Bar-Eli M & Gillily R (1978) Enhanced chemotactic and phagocytic activities of leukocytes in psoriasis. J Invest Dermatol 71: 186–188
Walker JR Littlewood SM, Dawson W & Allen BR (1983) Metabolism of (1–14C) arachidonic acid by peripheral blood cells from psoriatic patients. J Invest Dermatol 80: 359
Walsdorfer U, Christophers E & Schröder J-M (1983) Methotrexate inhibits polymorphonuclear leukocyte Chemotaxis in psoriasis. Br J Dermatol 108: 451–456
Williams TJ & Piper PJ (1980) The action of chemically pure SRS-A on the microcirculation in vivo. Prostaglandins 19: 779–789
Wong E, Camp RDR & Greaves MW (1984) Topical application of leukotriene B4 in psoriatic and normal subjects. J Invest Dermatol 82: 414
Wong E, Camp RDR & Greaves MW (1985) The responses of normal and psoriatic skin to single and multiple applications of leukotriene B4. J Invest Dermatol 84: 421–423
Wong PY-K, Westlund P, Hamberg M, Granström E, Chao PH-W & Samuelsson B (1984) ω-Hydroxylation of 12-L-hydroxy-5,8,10,14-eicosatetraenoic acid in human polymorphonuclear leukocytes. J Biol Chem 259: 2683–2686
Young JM, Spires DA, Bedord CJ, Wagner B, Bailaron SJ & de Young LM (1984) The mouse ear inflammatory response to topical arachidonic acid. J Invest Dermatol 82: 367–371
Ziboh VA, Casebolt I, Marcelo CL, Voorhees JJ (1983) Enhancement of 5-lipoxygenase activity in soluble preparations of human psoriatic plaque prepartions. J Invest Dermatol 80: 359
Ziboh VA, Casebolt I, Marcelo CL & Voorhees JJ (1984) Biosynthesis of lipoxygenase products by enzyme preparations from normal and psoriatic skin. J Invest Dermatol 83: 426–430
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Stüning, M., Raulf, M., König, W. (1987). Die Bedeutung der Arachidonsäure-Metaboliten für die Entzündungsreaktion. In: Holzmann, H., Altmeyer, P., Marsch, W.C., Vogel, H.G. (eds) Dermatologie und Rheuma. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-72668-2_3
Download citation
DOI: https://doi.org/10.1007/978-3-642-72668-2_3
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-72669-9
Online ISBN: 978-3-642-72668-2
eBook Packages: Springer Book Archive